Literature DB >> 11340250

Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.

A D Adekile1, R Gupta, F Yacoub, T Sinan, M Al-Bloushi, M Z Haider.   

Abstract

Avascular necrosis (AVN) of the hip is a common cause of morbidity in sickle cell disease (SCD). Its prevalence increases with age and predisposing factors include coexistent alpha-thalassemia trait, frequent vaso-occlusive crisis and a high hematocrit (Hct). SCD is relatively mild among Kuwaiti patients because of their elevated Hb F levels, but a subset exists with severe recurrent vaso-occlusive crises. We carried out a prospective magnetic resonance imaging (MRI) study of the hip in a group of patients being followed in the Pediatric Hematology clinics of Al-Mubarak and Al-Amiri Hospitals. The association of AVN with age, frequency of hospitalization, alpha-thal trait, steady-state Hb, Hct, Hb F, WBC and platelet counts was investigated. MRI was carried out with a 1.5-tesla GE unit with a super-conducting magnet. Thirty patients (19 males, 11 females) (23 SS and 7 SbetaThal) were studied. Their ages ranged from 6 to 17 years, with a mean of 9.8 +/- 3.5 years, and Hb F from 11 to 35% with a mean of 22.8 +/- 5.7%. Among the SS patients, 11 (47.8%) had coexistent alpha-thal trait (-3.7-kb deletion). A total of 8 (26.7%) patients (6 SS and 2 SbetaThal) had varying degrees of osteonecrosis of the hip. Four (36.4%) of the 11 SS patients with alpha-thal trait and 2 (16.7%) of those without alpha-thal trait had osteonecrosis. This difference is, however, not statistically significant (chi(2) = 0.3, p = 0.5). While there was also no significant difference in the mean age and hematological parameters (Hb, Hct, Hb F, WBC, platelets), the SS patients with osteonecrosis had a significantly higher number of hospitalizations for vaso-occlusive crisis in the preceding 3 years than those without osteonecrosis. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340250     DOI: 10.1159/000046529

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  21 in total

1.  Avascular Necrosis of the Hip in Sickle Cell Disease in Oman: Is it serious enough to warrant bone marrow transplantation?

Authors:  Yasser Wali; Sultan Almaskari
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

2.  Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.

Authors:  Tite Minga Mikobi; Prosper Tshilobo Lukusa; Michel Ntetani Aloni; Aimé Lumaka; Pierre Zalagile Akilimali; Koenraad Devriendt; Gert Matthijs; Jean-Marie Mbuyi Muamba; Valerie Race
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

3.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

4.  The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations.

Authors:  Amanda M Brandow; Steven J Weisman; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

Review 5.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

6.  Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  A L Akinyoola; I A Adediran; C M Asaleye; A R Bolarinwa
Journal:  Int Orthop       Date:  2008-07-17       Impact factor: 3.075

7.  Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional study.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Vitor Fortuna
Journal:  Int Orthop       Date:  2018-03-26       Impact factor: 3.075

Review 8.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

9.  Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.

Authors:  Abdulrahman Alsultan; Mohammed K Alabdulaali; Paula J Griffin; Ahmed M Alsuliman; Hazem A Ghabbour; Paola Sebastiani; Waleed H Albuali; Amein K Al-Ali; David H K Chui; Martin H Steinberg
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

Review 10.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.